Evidence map›Paper›PMID 32880041›Full record

ReviewJournal of gastrointestinal cancer2020

Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.

Ramazan Kutlu, Sinan Karatoprak

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of gastrointestinal cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Observational
  3. SIRT in 2025.Cardiovascular and interventional radiology · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ramazan KutluDepartment of Radiology, Inonu University School of Medicine & Liver Transplantation Institute, 44280, Malatya, Turkey. ramazan.kutlu@inonu.edu.tr.
Sinan KaratoprakDepartment of Radiology, Inonu University School of Medicine & Liver Transplantation Institute, 44280, Malatya, Turkey.
Inonu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHepatocellular carcinoma (HCC) is the most common primary liver tumor. Only about one third of them are eligible for curative treatments like liver transplantation. Various interventional oncologic treatment options could be employed for some of the HCC patients outside the acceptable liver transplantation criteria to make them suitable for transplantation by downstaging and keeping them inside the criteria by bridging to transplantation.

methodsWe reviewed the literature by the terms of downstaging and bridging therapy for liver transplantation.

resultsAbout only 30% of the patients are suitable for curative procedures like transplantation at the time of diagnosis of HCC. Even the Milan Criteria is expanded or new criteria are defined, still there are many patients who need downstaging to be eligible for transplantation. There are different procedures in interventional oncology for primary and metastatic liver lesions. Radioembolization (RE) is one of the locoregional therapies which is more effective than others for downstaging and bridging for liver transplantation.

conclusionDownstaging by RE is an effective and reasonable method for unresectable HCC cases initially beyond established criteria for liver transplantation by selecting suitable and favorable tumor biology.

Indexed as

BrachytherapyCarcinoma, HepatocellularEmbolization, TherapeuticHumansLiverLiver NeoplasmsLiver TransplantationNeoadjuvant TherapyNeoplasm Recurrence, LocalNeoplasm StagingPatient SelectionYttrium RadioisotopesYttrium-90Yttrium RadioisotopesDownstagingHepatocellular carcinomaLiver transplantRadioembolization

Identifiers

PMID32880041
OpenAlexW3083359792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.